Varian Medical (NYSE:VAR) said yesterday that it won 510(k) clearance from the FDA for its Nexus DR digital X-ray system. The Palo Alto-based company markets the device as a single common imaging platform intended for general radiographic procedures, but not for fluoroscopy, angiography, or mammography. The announcement comes a week after Varian acquired Polish distributor […]
Varian Medical Systems
Varian Medical buys Polish distributor
Varian Medical (NYSE:VAR) said yesterday that it acquired Polish distributor Candela for an undisclosed amount. Warsaw-based Candela, which employs 40 workers, was Varian’s distributor in Poland for 20 years. The deal closed yesterday after Polish anti-trust regulators OKed the transaction. “By bringing Candela’s radiotherapy business into the Varian family we hope to serve our Polish customers […]
Varian Medical shares rise after Street-beating Q3
Varian Medical (NYSE:VAR) saw shares rise 5% after releasing 3rd quarter earnings that handily beat the Street’s expectations. The Palo Alto, Calif.-based company reported profits of $98.9 million, or $1.04 per share, on sales of $789.4 million for the 3rd quarter. The bottom-line shrunk 12.9% as sales grew 0.7% compared to the same quarter in 2015. Adjusted […]
Varian Medical names spun-off imaging biz as Varex Imaging
Varian Medical (NYSE:VAR) yesterday released the name for its planned imaging component spin-off, running under the moniker “Varex Imaging.” The spin off will be a new, stand-alone public company separated through a tax-free distribution to Varian stockholders with the transaction expected to close by the end of 2016. The spun-off company will manufacture X-ray tubes, flat panel […]
Varian Medical to spin off imaging component biz
Varian Medical (NYSE:VAR) said today it plans to spin off its imaging components biz as a stand-alone public company by the end of this year. The Palo Alto, Calif.-based company said it plans to spin off the company through a tax-free distribution Varian stockholders, with the new company taking up the moniker Varian Imaging Components. “The […]
Varian backs Phase III non-small cell lung cancer trial
Varian Medical (NYSE:VAR) said today it is supporting a Phase III clinical trial set to compare outcomes of radiosurgery against surgical resection for treating early-stage, high-risk operable non-small cell lung cancer. The randomized “Stablemates Trial” will test the hypothesis that 3-year overall survival in high risk operable patients with Stage I NSCLC is equivalent or greater in […]
Varian Medical droops on Q1 misses
Varian Medical (NYSE:VAR) saw shares slump after posting Q1 earnings that missed the Street and saw profits and earnings per share shrinking. The Palo Alto, Calif.-based company reported profits of $89 million, or 92¢ per share, on sales of $757.1 million for the 3 months ended January 1. That adds up to a 4.6% bottom-line slide […]
RSNA Roundup: Researchers refine X-ray tech with Kinect gaming sensor
Microsoft’s (NSDQ:MSFT) Kinect, originally developed as a motion sensor for its Xbox gaming systems, is helping researchers refine X-ray imaging through analysis of body part thickness, motion and positioning, researchers said today, and with the use of the best wireless router
ITC grants Varian bid for Elekta investigation
The U.S. International Trade Commission said last week that it will begin an investigation into alleged Tariff Act violations by Elekta (STO:EKTA B), based on a complaint by arch-rival Varian Medical (NYSE:VAR). Varian makes the TruBeam and VitalBeam radiotherapy systems, which compete with Elekta’s Versa HD and Infinity devices. The ITC said Oct. 26 that it would […]
Varian Medical’s latest ProBeam wins CE Mark
Varian Medical (NYSE:VAR) said it won CE Mark approval in the European Union for its latest generation ProBeam proton therapy system. Proton therapy is designed for precise treatment of certain types of cancer while providing potentially fewer side effects than conventional radiation therapy, the Palo Alto, Calif.-based company said. In addition to precision, proton therapy reduces […]
Varian Medical wins FDA 510(k), CE Mark for VitalBeam
Varian Medical (NYSE:VAR) said today it won FDA 510(k) clearance and CE Mark approval in the European Union for its VitalBeam radiotherapy system. The VitalBeam system is a modular, high-throughput radiotherapy system which incorporates technology from the company’s TrueBeam radiotherapy system, the Palo Alto, Calif.-based company said. “The VitalBeam system will enable us to complete image-guided […]